Tilt mechanism and method for pivoting a vehicle body panel relative to a vehicle chassis
    1.
    发明授权
    Tilt mechanism and method for pivoting a vehicle body panel relative to a vehicle chassis 有权
    用于使车身面板相对于车辆底盘枢转的倾斜机构和方法

    公开(公告)号:US06454035B1

    公开(公告)日:2002-09-24

    申请号:US09490913

    申请日:2000-01-25

    IPC分类号: B62D2510

    CPC分类号: B62D33/067 B62D25/10

    摘要: A tilt mechanism for pivoting a vehicle body panel relative to a vehicle chassis includes a pivot pin having a pivot pin axis. The pivot pin provides a single-point pivot attachment of the body panel to the chassis such that the body panel can articulate about the pivot pin axis relative to the chassis. A support member pivotably connects to the chassis about the pivot pin axis by the pivot pin. The support member has a tilt axis along a longitudinal extent of the support member. The tilt axis is perpendicular to the pivot pin axis. The support member supports the vehicle body panel weight through a pivotal connection between a support member end and the body panel. The pivotal connection allows the body panel to pivot relative to the chassis about the tilt axis via a bearing. A torsion bar is within the support member. One portion of the torsion bar is secured to the support member and another portion is secured to the body panel by a slot that receives a torsion bar end. The torsion bar biases the body panel relative to the chassis along at least an angular portion of a pivotal range about the tilt axis. The slot is hour-glass-shaped such that the body panel can pivot about the tilt axis relative to the chassis without loading the torsion bar over a specified angular range about the tilt axis.

    摘要翻译: 用于使车身面板相对于车辆底盘枢转的倾斜机构包括具有枢轴销轴线的枢轴销。 枢轴销将主体面板的单点枢轴附接件提供到底架,使得主体面板可相对于底盘围绕枢轴销轴线铰接。 支撑构件通过枢轴销以枢转销轴线方式可枢转地连接到底盘。 支撑构件具有沿着支撑构件的纵向范围的倾斜轴。 倾斜轴垂直于枢轴销轴。 支撑构件通过支撑构件端部和主体面板之间的枢转连接来支撑车体面板重量。 枢转连接允许身体面板通过轴承绕倾斜轴线相对于底盘枢转。 扭力杆在支撑构件内。 扭杆的一部分被固定到支撑构件,另一部分通过容纳扭杆端部的狭槽固定到主体面板。 所述扭杆相对于所述底盘沿着所述倾斜轴线的枢转范围的至少一角度部分偏压所述主体面板。 狭槽是小时玻璃形的,使得主体面板可相对于底盘绕倾斜轴线转动,而不会将扭杆在围绕倾斜轴线的规定角度范围内加载。

    Apparatus and method for mounting a suspension system
    3.
    发明授权
    Apparatus and method for mounting a suspension system 有权
    用于安装悬挂系统的装置和方法

    公开(公告)号:US06209897B1

    公开(公告)日:2001-04-03

    申请号:US09354420

    申请日:1999-07-15

    IPC分类号: B60G1112

    摘要: An assembly for mounting a leaf spring suspension system to a vehicle. The assembly includes an arrangement of a plurality of shackles that movably secure at least a rear portion of a leaf spring, which carries an axle of the vehicle, to a frame of the vehicle.

    摘要翻译: 一种用于将叶簧悬挂系统安装到车辆的组件。 该组件包括多个手铐的装置,其将可携带车辆的车轴的板簧的至少后部可移动地固定到车辆的车架上。

    AMNION PUTTY FOR CARTILAGE REPAIR
    4.
    发明申请

    公开(公告)号:US20180271660A1

    公开(公告)日:2018-09-27

    申请号:US15935930

    申请日:2018-03-26

    申请人: Robert L. Bundy

    发明人: Robert L. Bundy

    IPC分类号: A61F2/30 A61L27/36

    摘要: There are disclosed compositions for achieving reverse phase characteristics, methods of preparation thereof, and the use of amniotic tissue for cartilage repair. In an embodiment, a biocompatible articular tissue repair composition may have a therapeutic material and a carrier configured for achieving reverse phase characteristics, and methods for using the composition. In various embodiments, the therapeutic material may be amniotic tissue. In various embodiments, the carrier may be a poloxamer such as poloxamer 407. Other embodiments are also disclosed.

    Synthetic, composite osteogenic bone graft

    公开(公告)号:US09642935B1

    公开(公告)日:2017-05-09

    申请号:US13752326

    申请日:2013-01-28

    IPC分类号: A61L27/22 A61L27/38 A61L27/58

    摘要: There is disclosed a synthetic, composite graft to support robust bone growth. In an embodiment, the synthetic, composite graft includes a synthetic scaffold material including a material resorbable through natural cellular processes; a signaling factor combined with the scaffold material; a cell adherence factor coated on the scaffold material; a quantity of viable bone forming cells adhered to the scaffold; and a matrix substrate binding the scaffold material. There is disclosed a method of forming a synthetic, composite graft to support bone growth for bone grafting. In one embodiment, the method includes providing a synthetic scaffold material including a material resorbable through natural cellular processes; combining a signaling factor with the scaffold material; coating a cell adherence factor on the scaffold material; adhering a quantity of viable bone forming cells to the scaffold; and encasing the scaffold material with a matrix substrate. Other embodiments are also disclosed.

    AMNION PUTTY FOR CARTILAGE REPAIR
    6.
    发明申请

    公开(公告)号:US20200345501A1

    公开(公告)日:2020-11-05

    申请号:US16927465

    申请日:2020-07-13

    申请人: Robert L. Bundy

    发明人: Robert L. Bundy

    IPC分类号: A61F2/30 A61L27/36 A61L27/38

    摘要: There are disclosed compositions for achieving reverse phase characteristics, methods of preparation thereof, and the use of amniotic tissue for cartilage repair. In an embodiment, a biocompatible articular tissue repair composition may have a therapeutic material and a carrier configured for achieving reverse phase characteristics, and methods for using the composition. In various embodiments, the therapeutic material may be amniotic tissue. In various embodiments, the carrier may be a poloxamer such as poloxamer 407. Other embodiments are also disclosed.

    Amnion putty for cartilage repair

    公开(公告)号:US10743996B2

    公开(公告)日:2020-08-18

    申请号:US15935930

    申请日:2018-03-26

    申请人: Robert L. Bundy

    发明人: Robert L. Bundy

    摘要: There are disclosed compositions for achieving reverse phase characteristics, methods of preparation thereof, and the use of amniotic tissue for cartilage repair. In an embodiment, a biocompatible articular tissue repair composition may have a therapeutic material and a carrier configured for achieving reverse phase characteristics, and methods for using the composition. In various embodiments, the therapeutic material may be amniotic tissue. In various embodiments, the carrier may be a poloxamer such as poloxamer 407. Other embodiments are also disclosed.